1.21
-0.02(-1.63%)
Currency In USD
| Previous Close | 1.23 |
| Open | 1.23 |
| Day High | 1.25 |
| Day Low | 1.21 |
| 52-Week High | 3.2 |
| 52-Week Low | 1 |
| Volume | 42,394 |
| Average Volume | 77,895 |
| Market Cap | 7.02M |
| PE | -0.85 |
| EPS | -1.42 |
| Moving Average 50 Days | 1.34 |
| Moving Average 200 Days | 1.78 |
| Change | -0.02 |
If you invested $1000 in BioCardia, Inc. (BCDA) 10 years ago, it would be worth $2.77 as of February 02, 2026 at a share price of $1.21. Whereas If you bought $1000 worth of BioCardia, Inc. (BCDA) shares 5 years ago, it would be worth $6.48 as of February 02, 2026 at a share price of $1.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
GlobeNewswire Inc.
Dec 16, 2025 1:00 PM GMT
SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary c
BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
SUNNYVALE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the election of Mr. Marvin Sl
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
GlobeNewswire Inc.
Dec 01, 2025 1:30 PM GMT
SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it will participate at the CS